These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Similar mechanism of various lupus anticoagulants. Exner T. Thromb Haemost; 1985 Feb 18; 53(1):15-8. PubMed ID: 3922078 [Abstract] [Full Text] [Related]
24. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME, Cabiedes J, Reyes E, Cabral AR. Rev Invest Clin; 2005 Feb 18; 57(4):563-71. PubMed ID: 16315641 [Abstract] [Full Text] [Related]
25. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C. Lupus; 2007 Feb 18; 16(10):810-6. PubMed ID: 17895304 [Abstract] [Full Text] [Related]
27. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant. Robert A. Thromb Haemost; 1994 Feb 18; 71(2):220-4. PubMed ID: 8191402 [Abstract] [Full Text] [Related]
29. A lupus anticoagulant neutralization procedure using the patient's own platelets. Carroll P, Ray M, Just S, Hawson G. Blood Coagul Fibrinolysis; 1994 Aug 18; 5(4):523-7. PubMed ID: 7841308 [Abstract] [Full Text] [Related]
30. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G. Blood Coagul Fibrinolysis; 1992 Aug 18; 3(4):407-14. PubMed ID: 1420816 [Abstract] [Full Text] [Related]
31. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M. Haematologica; 2000 Jun 18; 85(6):632-7. PubMed ID: 10870121 [Abstract] [Full Text] [Related]
34. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ. Semin Thromb Hemost; 2005 Jun 18; 31(4):426-40. PubMed ID: 16149021 [Abstract] [Full Text] [Related]
35. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1). Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Thromb Haemost; 1990 Nov 30; 64(3):478-84. PubMed ID: 2128977 [Abstract] [Full Text] [Related]
36. Coagulation abnormalities in systemic lupus erythematosus. Saraya AK, Rai R, Saxena R, Singh RR, Padmakumar K, Malaviya AN. Indian J Med Res; 1989 Oct 30; 90():335-40. PubMed ID: 2628301 [Abstract] [Full Text] [Related]
39. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M. Thromb Haemost; 1997 May 30; 77(5):934-7. PubMed ID: 9184405 [Abstract] [Full Text] [Related]